Newsletters

Psychiatry Advisor

• ADHD Medications Associated With Reduced Risk for Suicidality, Hospitalizations April 24, 2024
  Researchers used Swedish national register data to evaluate the effect of ADHD medication use on work disability and mental health outcomes. The post ADHD Medications Associated With Reduced Risk for Suicidality, Hospitalizations appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• In-Person Schooling Aids Pediatric Mental Health for Urban, Minoritized Children April 24, 2024
  Researchers conducted a longitudinal study to examine pediatric mental health among urban, minoritized children during the first 2 years of the pandemic. The post In-Person Schooling Aids Pediatric Mental Health for Urban, Minoritized Children appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Medications Still Effective for Treating ADHD in Children April 24, 2024
  Medication therapy remains an important treatment for children with attention-deficit/hyperactivity disorder (ADHD). The post Medications Still Effective for Treating ADHD in Children appeared first on Psychiatry Advisor.
  Haymarket Media
• Many Stroke Survivors Experience Poststroke Depression April 24, 2024
  Nearly 6 in 10 stroke survivors experience depression up to 18 years after stroke, according to a study published online. The post Many Stroke Survivors Experience Poststroke Depression appeared first on Psychiatry Advisor.
  Haymarket Media
• Botulinum Toxin Type A Injection Reduced Pain, Attacks in Trigeminal Neuralgia April 24, 2024
  In a systematic review and meta-analysis, researchers evaluated data supporting the use of botulinum toxin type A injection for trigeminal neuralgia and assessed its efficacy and safety. The post Botulinum Toxin Type A Injection Reduced Pain, Attacks in Trigeminal Neuralgia appeared first on Psychiatry Advisor.
  melissaalvarez
• REFORM: Predominant Visual Aura Symptoms Found in Migraine With Aura April 24, 2024
  Due to the limited data available, researchers conducted the study to investigate adult patients with migraine who were scheduled to participate in a phase IV trial. The post REFORM: Predominant Visual Aura Symptoms Found in Migraine With Aura appeared first on Psychiatry Advisor.
  melissaalvarez
• FDA Decision on Apomorphine Infusion Device Delayed Again April 24, 2024
  The drug/device combination therapy provides a continuous subcutaneous infusion of apomorphine through an infusion pump. The post FDA Decision on Apomorphine Infusion Device Delayed Again appeared first on Psychiatry Advisor.
  Diana Ernst, RPh
• March 2024: Notable Drug Approvals April 24, 2024
  A review of FDA drug approvals in March 2024, aimed to treat disorders in a variety of health specialties. The post March 2024: Notable Drug Approvals appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Childhood Sleep Latency Associated With Depression, ADHD in Adolescence April 23, 2024
  Investigators conducted a longitudinal study to determine if childhood sleep trajectories are associated with mental health problems and disorders during adolescence. The post Childhood Sleep Latency Associated With Depression, ADHD in Adolescence appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Having 1 Drink Per Day Increases Your Risk for Alcohol Use Disorder April 23, 2024
  Researchers conducted a systematic review and analysis to evaluate the relationship between average alcohol consumption and AUD and AUD-related mortality. The post Having 1 Drink Per Day Increases Your Risk for Alcohol Use Disorder appeared first on Psychiatry Advisor.
  Meahjabeen Hoque